Search
Diabetic Macular Edema Clinical Trials
A listing of 16 Diabetic Macular Edema clinical trials actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
1 - 12 of 16
Featured Trial
Paid Clinical Studies Nationwide
Recruiting
Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.
Conditions:
Healthy
Healthy Volunteer Study
Featured Trial
Resistant Hypertension Clinical Trial
Recruiting
This clinical trial is seeking volunteers that take blood pressure medications daily and still routinely have a systolic (top number) blood pressure above 145.
Conditions:
High Blood Pressure
Hypertension
Resistant Hypertension
Featured Trial
Herpes Clinical Trial
Recruiting
Help move the future of herpes simplex virus type 2 (HSV-2) genital herpes forward by participating in the Vantage Trial for an investigational vaccine.
Conditions:
HSV-2 Infection
HSV-2
Herpes
Herpes Simplex
Genital Herpes
Genital Herpes Simplex Type 2
HSV-2 Genital Herpes
HIV-1 and HSV-2 Coinfection
Featured Trial
Fronto-Temporal Dementia Research Study
Recruiting
The aim of this study is to better understand the genetics of FTD, in order to
empower researchers with the data they need to potentially identify treatment
options. Help researchers accelerate their understanding of Frontotemporal
Dementia and get access to free, at-home genetic testing and genetic counseling
before and after your test.
empower researchers with the data they need to potentially identify treatment
options. Help researchers accelerate their understanding of Frontotemporal
Dementia and get access to free, at-home genetic testing and genetic counseling
before and after your test.
Conditions:
Dementia
Frontotemporal Dementia
Alzheimer Dementia
Dementia Alzheimers
Mild Dementia
Dementia
Alzheimer Type
Alzheimer Disease
Alzheimer's Disease
Dementia of Alzheimer Type
Parkinson's Disease
Parkinson Disease
Idiopathic Parkinson's Disease
ALS
Memory Disorders
Memory Impairment
Memory Loss
Age-Related Memory Disorders
A Study to Investigate Faricimab Treatment Response in Treatment-Naive, Underrepresented Patients With Diabetic Macular Edema
Recruiting
This study is designed to investigate treatment response in treatment-naïve underrepresented patients with diabetic macular edema (DME) who are treated with faricimab. The study population will consist of participants ≥18 years of age who self-identify as Black/African American, Hispanic/Latino American, or Native American/Alaska Native/Native Hawaiian or other Pacific Islander; in addition, a cohort of Asian Indian participants will be enrolled in India.
Gender:
All
Ages:
18 years and above
Trial Updated:
11/29/2023
Locations: Barnet Dulaney Perkins Eye Center, Mesa, Arizona +46 locations
Conditions: Diabetic Macular Edema
Treat & Extend Versus Fixed Dosing With Faricimab for Management of Diabetic Macular Edema: A Pragmatic, Multi-center, Open-label, Randomized, Controlled Trial
Recruiting
This study will assess a pragmatic, treat and extend regimen of faricimab against the standard of a fixed dosing regimen.
Gender:
All
Ages:
18 years and above
Trial Updated:
11/24/2023
Locations: University Retina and Macula Associates, Oak Forest, Illinois +33 locations
Conditions: Diabetic Macular Edema
Study to Evaluate the Efficacy and Safety of RZ402 in Diabetic Macular Edema (DME)
Recruiting
The objective of this trial is to assess the safety, efficacy, and tolerability of RZ402 in patients with Diabetic Macular Edema.
Gender:
All
Ages:
Between 18 years and 75 years
Trial Updated:
11/16/2023
Locations: Rezolute Investigative Site, Phoenix, Arizona, Phoenix, Arizona +27 locations
Conditions: Diabetic Macular Edema
A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products
Recruiting
The VOYAGER study is a primary data collection, non-interventional, prospective, multinational, multicenter study. It is designed to collect real-world, long-term data to explore long-term effectiveness, safety, clinical insights, treatment patterns, and factors driving the treatment decisions among patients being treated with specified Roche ophthalmology products (Faricimab and Port Delivery System with Ranibizumab) in approved retinal indications (neovascular age-related macular degeneration... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
11/06/2023
Locations: Retinal Research Institute, LLC, Phoenix, Arizona +39 locations
Conditions: Neovascular Age-related Macular Degeneration, Diabetic Macular Edema
A Study to Investigate RO7200220 in Diabetic Macular Edema
Recruiting
Study BP43445 is a phase II, multicenter, randomized, double-masked, active comparator-controlled study to investigate the efficacy, safety, tolerability, pharmacokinetics, and pharmacodynamics of RO7200220 administered intravitreally in participants with diabetic macular edema. Only one eye will be chosen as the study eye. The duration of the study will be up to 76 weeks.
Gender:
All
Ages:
18 years and above
Trial Updated:
11/02/2023
Locations: Win Retina, Arcadia, California +85 locations
Conditions: Diabetic Macular Edema
Assess the Efficacy and Safety of Repeat Intravitreal Injections of Foselutoclax (UBX1325) in Patients With DME (ASPIRE)
Recruiting
The goal of this clinical trial is to assess the efficacy and safety of multiple doses of foselutoclax (UBX1325) in patients with Diabetic Macular Edema. The main questions the study aims to answer are:
Assess the efficacy of foselutoclax compared to aflibercept
Assess the safety and tolerability of foselutoclax
Gender:
All
Ages:
18 years and above
Trial Updated:
10/24/2023
Locations: California Retina Consultants, Bakersfield, California +16 locations
Conditions: Diabetic Macular Edema, Retinal Disease, Macular Edema, Diabetes Mellitus, Diabetic Retinopathy, Retinal Degeneration, Retinal Diseases, Eye Diseases, Edema
Suprachoroidal Sustained-Release OXU-001 Compared to Intravitreal Ozurdex® in the Treatment of Diabetic Macular Edema
Recruiting
The purpose of this clinical trial is to compare safety, tolerability, efficacy, and durability of two dose levels of suprachoroidal sustained-release OXU-001 (dexamethasone microspheres; DEXAspheres®) using the Oxulumis® illuminated microcatheterization device compared with intravitreal dexamethasone implant (OZURDEX®) in subjects with diabetic macular edema.
Gender:
All
Ages:
18 years and above
Trial Updated:
09/28/2023
Locations: Retinal Research Institute, LLC, Phoenix, Arizona +8 locations
Conditions: Diabetic Macular Edema
Evaluation of Tonabersat for DME
Recruiting
This randomized clinical trial will evaluate the effect of tonabersat compared with placebo on central subfield thickness (CST) in eyes with center-involved diabetic macular edema (CI-DME) and good visual acuity.
Gender:
All
Ages:
18 years and above
Trial Updated:
09/25/2023
Locations: Retina Associates of Southern California, Huntington Beach, California +14 locations
Conditions: Diabetic Macular Edema
4D-150 in Patients With Diabetic Macular Edema
Recruiting
Phase 2 randomized, active-controlled, double-masked, dose-ranging trial in adults with Diabetic Macular Edema (DME).
Gender:
All
Ages:
18 years and above
Trial Updated:
08/29/2023
Locations: National Ophthalmic Research Institute, Fort Myers, Florida +6 locations
Conditions: Diabetic Macular Edema, Diabetic Retinopathy
AG-73305 Single Ascending Dose Cohort Study in DME
Recruiting
This is a multi-centered, open-labeled, single ascending-dose-cohort study to evaluate 4 dosing cohorts of AG-73305 administered by intravitreal injection in patients with diabetic macular edema (DME).
Gender:
All
Ages:
18 years and above
Trial Updated:
07/18/2023
Locations: Retina Research Institute of Texas, Abilene, Texas +1 locations
Conditions: Diabetic Macular Edema
Effect of AIV007 by Periocular Administration in Subjects With nAMD or DME
Recruiting
To determine safety, pharmacokinetics, and duration of effect of periocularly administered AIV007 gel suspension in subjects with neovascular age-related macular degeneration (nAMD) or diabetic macular edema (DME).
Gender:
All
Ages:
Between 21 years and 90 years
Trial Updated:
03/28/2023
Locations: Retina Consultants of Austin, Austin, Texas
Conditions: Neovascular Age-related Macular Degeneration, Diabetic Macular Edema
Safety and Effect of Intravitreal Injection of a Derivative of Nucleoside Reverse Transcriptase Inhibitor in Subjects With Diabetic Macular Edema
Recruiting
This study is designed to assess the safety and initial evidence of efficacy of the novel compound SOM-401 (K8), a derivative of a nucleoside reverse transcriptase inhibitor, in subjects with untreated, clinically significant, diabetic macular edema (DME).
Gender:
All
Ages:
18 years and above
Trial Updated:
03/13/2023
Locations: University of Kentucky, Lexington, Kentucky
Conditions: Diabetic Macular Edema
1 - 12 of 16